Sunset, Louisiana (PRWEB) September 15, 2015
The August edition of CEO/CFO Magazine features an interview with JayMac Pharmaceuticals CEO, Harold "Towny" Robinson. JayMac Pharmaceuticals has gained much attention due to its cutting-edge RX folate therapies, EnLyte and EnBrace HR. CEO/CFO Magazine is widely known as the most powerful name in corporate news and information. The full interview can be found here:
“People should pay attention to JayMac Pharmaceuticals primarily because our products have caught up to the science of the need for personalizing medication. EnLyte and EnBrace HR provide targeted folate needs for specific patient types, and if you can treat those patients’ folate deficiencies safely and effectively then you are way ahead of the game. Getting to the root cause of disease issues is very exciting.” -Towny Robinson, CEO, JayMac Pharmaceuticals
For questions, licensed prescriber samples or copay coupons, contact us now: 985-788-7755.